Gene · 5029
Papers2,260
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,260
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Machine Learning-Guided Approach for Identifying Potential HCAR1 Antagonists in Lactate-Driven Cancers. | ACS Omega | 2026 | 41726659 | PubTator, text mining | PubMed |
| Free fatty acid receptor 2 allosterism is defined by cellular context. | Cell Commun Signal | 2026 | 41709222 | PubTator, text mining | PubMed |
| Efferocytosis deficiency exacerbates local inflammation and predicts recurrence in chronic rhinosinusitis with nasal polyps. | J Allergy Clin Immunol | 2026 | 41638263 | PubTator, text mining | PubMed |
| Timing of Glucocorticoid Treatment Dictates Glucocorticoid Receptor Actions Modulating the NLRP3-Inflammasome Activation in Macrophages. | FASEB J | 2026 | 41623187 | PubTator, text mining | PubMed |
| Emerging Mechanisms of Abdominal Aortic Aneurysm. | Curr Atheroscler Rep | 2026 | 41615587 | PubTator, text mining | PubMed |
| Extracellular acidity and ATP modulate ion currents in human cumulus cells indicating possible roles as metabolic sensors of the follicular microenvironment. | Physiol Rep | 2026 | 41603488 | PubTator, text mining | PubMed |
| The purinergic signaling interfaces in breast cancer angiogenesis. | Purinergic Signal | 2026 | 41575692 | PubTator, text mining | PubMed |
| A genome-wide genetic screen reveals the P2Y2-integrin axis as a stabilizer of EGFR mutants in non-small cell lung cancer (NSCLC). | Sci Adv | 2026 | 41564171 | PubTator, text mining | PubMed |
| Abnormal purinergic signaling contributes to development of renal cysts in autosomal dominant polycystic kidney disease. | Purinergic Signal | 2026 | 41557043 | PubTator, text mining | PubMed |
| MitoCommun: a database for decoding mitochondrial communication networks. | BMC Genomics | 2026 | 41545919 | PubTator, text mining | PubMed |
| Current understanding of ENaC regulation by P2Y2/PLC/PI(4,5)P2 pathway. | Purinergic Signal | 2026 | 41498836 | PubTator, text mining | PubMed |
| Damage-induced pyroptosis drives endogenous thymic regeneration by activating the purinergic receptor P2Y2. | Cell Death Dis | 2026 | 41484087 | PubTator, text mining | PubMed |
| P2Y2 receptor as a favorable predictor of gastric cancer. | Tissue Cell | 2026 | 41418432 | PubTator, text mining | PubMed |
| From tetrazole to isoquinolinone: Structure-based optimization and late-stage diversification of AR-C118925-derived P2Y2 receptor antagonists. | Eur J Med Chem | 2026 | 41223566 | PubTator, text mining | PubMed |
| Understanding Fascial Tissue on the Molecular Level-How Its Unique Properties Enable Adaptation or Dysfunction. | Int J Mol Sci | 2025 | 41516037 | PubTator, text mining | PubMed |
| Extracellular ATP Suppresses Perlecan Core Protein Synthesis via P2Y2 Receptor-Mediated Inhibition of Akt Signaling in Cultured Vascular Endothelial Cells. | Int J Mol Sci | 2025 | 41303456 | PubTator, text mining | PubMed |
| Purinergic Receptors in Dendritic Cells. | J Inflamm Res | 2025 | 41049073 | PubTator, text mining | PubMed |
| Expression profiles of purinergic P1 and P2 receptors in cultured bovine aortic endothelial cells, bovine aortic smooth muscle cells, and human vascular endothelial EA.hy926 cells. | J Toxicol Sci | 2025 | 41034045 | PubTator, text mining | PubMed |
| Empowering Pharmacists in Heartburn Management: Practical Insights for OTC Treatment and Self-Care. | Pharmacy (Basel) | 2025 | 40981244 | PubTator, text mining | PubMed |
| Deciphering the role of polyethylene glycol-lipid anchors in siRNA-LNP efficacy for P2y2 inhibition in bone marrow-derived macrophages. | Int J Pharm | 2025 | 40967321 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5029/papers?page=2